Antiemetic Therapy
0
Pipeline Programs
1
Companies
4
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
M&
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
Merck & Co.non-interventional
Merck & Co.non-interventional
Merck & Co.non-interventional
Merck & Co.non-interventional
Clinical Trials (4)
Total enrollment: 1,146 patients across 4 trials
Data-Driven Strategies for Patient Engagement About Cancer Clinical Trials
Start: Nov 2024Est. completion: Nov 202750 patients
N/ARecruiting
Non-interventional Study to Assess Adherence to Treatment for Patients With RMS (MAIN-MS)
Start: Jun 2016Est. completion: Jul 2020
N/ACompleted
A Scandinavian Non-interventional Study of Adherence to RebiSmart Administered Rebif New Formulation (RNF) Treatment in Relapsing Remitting Multiple Sclerosis (RRMS) Subjects
Start: Aug 201061 patients
N/ACompleted
Epidemiological EMESIS-Registry
Start: Oct 2008Est. completion: Aug 20091,035 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 1,146 patients
1 companies competing in this space